Kenneth C. Frazier's Insider Trades & SAST Disclosures
Kenneth C. Frazier's most recent trade in Merck & Co Inc was a trade of 235,769 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 7, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kenneth C. Frazier.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 235,769 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 235,769 | 936,422 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.42 per share. | 07 Nov 2022 | 126,134 | 785,374 (0%) | 0% | 99.4 | 12,540,835 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 100.07 per share. | 07 Nov 2022 | 84,721 | 700,653 (0%) | 0% | 100.1 | 8,477,717 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 98.45 per share. | 07 Nov 2022 | 24,914 | 911,508 (0%) | 0% | 98.5 | 2,452,880 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 235,000 | 235,769 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 235,000 | 470,769 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 235,000 | 935,653 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 235,000 | 935,653 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 98.68 per share. | 03 Nov 2022 | 214,617 | 721,036 (0%) | 0% | 98.7 | 21,178,084 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 98.53 per share. | 03 Nov 2022 | 200,190 | 735,463 (0%) | 0% | 98.5 | 19,725,241 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.08 per share. | 03 Nov 2022 | 34,810 | 700,653 (0%) | 0% | 99.1 | 3,448,989 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.09 per share. | 03 Nov 2022 | 20,383 | 700,653 (0%) | 0% | 99.1 | 2,019,804 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 300,000 | 1,006,283 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 300,000 | 165,828 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.68 per share. | 01 Nov 2022 | 205,661 | 794,992 (0%) | 0% | 99.7 | 20,500,103 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.61 per share. | 01 Nov 2022 | 202,319 | 803,964 (0%) | 0% | 99.6 | 20,152,287 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 165,828 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 165,828 | 866,481 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 134,172 | 705,769 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 134,172 | 1,000,653 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 100.22 per share. | 01 Nov 2022 | 96,981 | 706,983 (0%) | 0% | 100.2 | 9,719,843 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 100.40 per share. | 01 Nov 2022 | 94,339 | 700,653 (0%) | 0% | 100.4 | 9,471,739 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Nov 2022 | 2,450 | 702,123 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Nov 2022 | 1,710 | 704,573 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Nov 2022 | 1,470 | 700,653 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 101.05 per share. | 01 Nov 2022 | 700 | 706,283 (0%) | 0% | 101.0 | 70,733 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 567,084 | 1,273,367 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 567,084 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 100.25 per share. | 28 Oct 2022 | 313,232 | 884,646 (0%) | 0% | 100.3 | 31,402,730 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 300,000 | 465,828 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 300,000 | 1,006,283 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 101.03 per share. | 28 Oct 2022 | 229,302 | 706,283 (0%) | 0% | 101.0 | 23,167,321 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 100.80 per share. | 28 Oct 2022 | 178,363 | 706,283 (0%) | 0% | 100.8 | 17,978,687 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.15 per share. | 28 Oct 2022 | 75,489 | 1,197,878 (0%) | 0% | 99.2 | 7,484,855 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 99.82 per share. | 28 Oct 2022 | 70,698 | 935,585 (0%) | 0% | 99.8 | 7,056,770 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 28,532 | 28,532 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 28,703 | 28,703 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 119,488 | 706,283 (0%) | 0% | 73.5 | 8,783,563 | Common Stock |
| Exxon Mobil Corp. | Kenneth C. Frazier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 2,500 | 40,500 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 663,881 | 1,250,676 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 663,881 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 82.22 per share. | 09 Nov 2021 | 634,266 | 616,410 (0%) | 0% | 82.2 | 52,146,496 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 83.23 per share. | 09 Nov 2021 | 29,615 | 586,795 (0%) | 0% | 83.2 | 2,464,865 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 329,082 | 329,082 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 72.62 per share. | 26 Feb 2021 | 175,249 | 586,795 (0%) | 0% | 72.6 | 12,726,582 | Common Stock |
| Exxon Mobil Corp. | Kenneth C. Frazier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 2,500 | 38,000 (0%) | 0% | - | Common Stock | |
| Merck & Co Inc | Kenneth C. Frazier | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 81.74 per share. | 09 Nov 2020 | 144,866 | 411,546 (0%) | 0% | 81.7 | 11,840,941 | Common Stock |
| Merck & Co Inc | Kenneth C. Frazier | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 81.08 per share. | 09 Nov 2020 | 135,134 | 556,412 (0%) | 0% | 81.1 | 10,956,070 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges